A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

C. Pellegrini, A. Dodero, Annalisa Chiappella, F. Monaco, D. Degl'Innocenti, F. Salvi, U. Vitolo, Lisa Argnani, P. Corradini, Pier Luigi Zinzani

Research output: Contribution to journalArticlepeer-review

Cite this